Resources & Peer-reviewed publications

Comparative analysis of the oral and injectable form of heat-inactivated Salmonella Enteritidis vaccine efficacy in commercial chickens

Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25.

Vet Q

Peer-reviewed article

01 Dec 2025

A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.

Hum Vaccin Immunother

Peer-reviewed article

01 Dec 2025

A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets.

Virulence

Peer-reviewed article

Closes: 21 November 2025

Postdoctoral Research Associate

We are seeking a highly motivated and innovative scientist to join the Mucosal Immunology Group at contributing to a transformative research programme supported by the Bill & Melinda Gates Foundation (BMGF) and BBSRC Institute Strategic Programme Grants.

The Pirbright Institute

Vacancy

Closes: May 2026

CEPI Call for Proposals

CEPI has launched a Call for Proposals with a budget of up to $10.7 million to meet the scale of the challenge by advancing technologies that monitor vaccine manufacturing processes, ensuring quality, safety, global scalability and accessibility, all while accelerating product release.

Funding

01 Nov 2025

Virus-like particle-based liquid phase blocking ELISA for evaluating the efficacy of O-type foot-and-mouth disease vaccines.

Appl Microbiol Biotechnol

Peer-reviewed article

31 Oct 2025

Development of a Promising Ferritin-Based Bioconjugate Nanovaccine Candidate against Brucellosis.

ACS Infect Dis

Peer-reviewed article

31 Oct 2025

Investigation into the efficacy of a commercially available inactivated avian influenza virus (AIV) vaccine (H9N2) through experimental and field assessments, with an emphasis on its compatibility with recent AIV (H9N2) G1-sublineage isolates.

Vet Res Commun

Peer-reviewed article

30 Oct 2025

An inactivated vaccine against acquired Toxoplasma gondii infection in pigs as a tool to minimize the zoonotic transmission risk.

Vet Res

Peer-reviewed article

30 Oct 2025

Poultry Technical Services Manager

ECO Animal Health have a new vacancy based in Europe within the Technical Team - Poultry Technical Services Manager, Biologics, EUROPE.

ECO, Animal Health

Vacancy

29 Oct 2025

Rickettsia rickettsii inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used.

Infect Immun

Peer-reviewed article

IVVN

Search

Resources & Peer-reviewed publications

Comparative analysis of the oral and injectable form of heat-inactivated Salmonella Enteritidis vaccine efficacy in commercial chickens

Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25.

A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.

A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets.

Postdoctoral Research Associate

CEPI Call for Proposals

Virus-like particle-based liquid phase blocking ELISA for evaluating the efficacy of O-type foot-and-mouth disease vaccines.

Development of a Promising Ferritin-Based Bioconjugate Nanovaccine Candidate against Brucellosis.

Investigation into the efficacy of a commercially available inactivated avian influenza virus (AIV) vaccine (H9N2) through experimental and field assessments, with an emphasis on its compatibility with recent AIV (H9N2) G1-sublineage isolates.

An inactivated vaccine against acquired Toxoplasma gondii infection in pigs as a tool to minimize the zoonotic transmission risk.

Poultry Technical Services Manager

Rickettsia rickettsii inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used.

Pages

Comparative analysis of the oral and injectable form of heat-inactivated Salmonella Enteritidis vaccine efficacy in commercial chickens

Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25.

A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.

A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets.

Postdoctoral Research Associate

CEPI Call for Proposals

Virus-like particle-based liquid phase blocking ELISA for evaluating the efficacy of O-type foot-and-mouth disease vaccines.

Development of a Promising Ferritin-Based Bioconjugate Nanovaccine Candidate against Brucellosis.

Investigation into the efficacy of a commercially available inactivated avian influenza virus (AIV) vaccine (H9N2) through experimental and field assessments, with an emphasis on its compatibility with recent AIV (H9N2) G1-sublineage isolates.

An inactivated vaccine against acquired Toxoplasma gondii infection in pigs as a tool to minimize the zoonotic transmission risk.

Poultry Technical Services Manager

Rickettsia rickettsii inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used.

Pages

Contact us

Follow us